Daniel Falkenhain‐López
-
- Cutaneous lymphoproliferative disorders research 3
- Dermatological and COVID-19 studies 3
-
- Lymphoma Diagnosis and Treatment 3
- Autoimmune Bullous Skin Diseases 2
-
- Urticaria and Related Conditions 2
-
- CAR-T cell therapy research 2
-
- Psoriasis: Treatment and Pathogenesis 2
-
- Drug-Induced Adverse Reactions 2
- Co-authors
- F.J. Ortiz de FrutosJosé Luis Rodríguez‐PeraltoPablo L. Ortiz‐RomeroJorge Arroyo‐AndrésR. RiveraManuel Agud‐DiosAntonia Rodríguez IzquierdoAn Wang
- Journals
- European Journal of Cancer (1 paper)British Journal of Dermatology (1 paper)Clinical and Experimental Dermatology (1 paper)
- Partner nations
- SpainUnited States
In The Last Decade
Daniel Falkenhain‐López
10 papers receiving 26 citations
Peers
Comparison fields: 5 of 18
- Dermatology 22
- Infectious Diseases 8
- Periodontics 2
- Pathology and Forensic Medicine 6
- Rheumatology 5
Countries citing papers authored by Daniel Falkenhain‐López
This map shows the geographic impact of Daniel Falkenhain‐López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Falkenhain‐López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Falkenhain‐López more than expected).
Fields of papers citing papers by Daniel Falkenhain‐López
This network shows the impact of papers produced by Daniel Falkenhain‐López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Falkenhain‐López. The network helps show where Daniel Falkenhain‐López may publish in the future.
Co-authorship network
The 10 scholars most cited alongside Daniel Falkenhain‐López, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 2 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 0 | |
| 7 | 2021 | 1 | |
| 8 | 2020 | 5 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 1 | |
| 11 | 2020 | 2 | |
| 12 | 2020 | 8 |
About Daniel Falkenhain‐López
Daniel Falkenhain‐López is a scholar working on Dermatology, Pathology and Forensic Medicine and Periodontics, having authored 12 papers that have together received 26 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (3 papers), Cutaneous lymphoproliferative disorders research (3 papers), Dermatological and COVID-19 studies (3 papers), CAR-T cell therapy research (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Drug-Induced Adverse Reactions (2 papers), Autoimmune Bullous Skin Diseases (2 papers) and Urticaria and Related Conditions (2 papers). The work is most often cited by research in Dermatology (22 citations), Infectious Diseases (8 citations) and Periodontics (2 citations). Daniel Falkenhain‐López has collaborated with scholars based in Spain and United States. Frequent co-authors include F.J. Ortiz de Frutos, José Luis Rodríguez‐Peralto, Pablo L. Ortiz‐Romero, Jorge Arroyo‐Andrés, R. Rivera, Manuel Agud‐Dios, Antonia Rodríguez Izquierdo, An Wang, Julia Montero‐Menárguez and Borja González Rodríguez. Their work appears in journals such as European Journal of Cancer, British Journal of Dermatology and Clinical and Experimental Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.